{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:48:53Z","timestamp":1788241733000,"version":"build-2803163510"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s279332","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T12:15:07Z","timestamp":1701346507000},"page":"1019-1024","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington\u2019s Disease and Tardive Dyskinesia"],"prefix":"10.2147","volume":"Volume 19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-162X","authenticated-orcid":true,"given":"Samuel","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljoharah","family":"Alakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1017\/S109285291700061X","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2018.11.017","volume":"59","author":"Frei","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/med.20187","volume":"31","author":"Wimalasena","year":"2011","journal-title":"Med Res Rev"},{"key":"ref4","first-page":"761","volume":"81","author":"Benarroch","year":"2013","journal-title":"Structure Regulation Clin Implications"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1080\/14656566.2016.1258063","volume":"17","author":"Jankovic","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1586\/14737175.6.1.7","volume":"6","author":"Kenney","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"ref7","unstructured":"Reserpine [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557767\/. Accessed November 17, 2023."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/CON.0000000000000763","volume":"25","author":"Termsarasab","year":"2019","journal-title":"Continuum"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/14737175.2018.1455504","volume":"18","author":"Citrome","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/WNF.0000000000000326","volume":"42","author":"Niemann","year":"2019","journal-title":"Clin Neuropharmacol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s40265-017-0831-0","volume":"77","author":"Heo","year":"2017","journal-title":"Drugs"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/mds.26021","volume":"29","author":"Sampaio","year":"2014","journal-title":"Mov Disorders"},{"key":"ref13","first-page":"46","volume":"71","author":"Citrome","year":"2017","journal-title":"Int J Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2217\/nmt-2018-0040","volume":"9","author":"Richard","year":"2019","journal-title":"Neurodegener Dis Manag"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/jnnp-2018-319918","volume":"90","author":"Fernandez","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","volume":"396","author":"Testa","year":"2019","journal-title":"J Neurol Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jama.2016.8655","volume":"316","author":"Frank","year":"2016","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/mdc3.12483","volume":"4","author":"Rodrigues","year":"2017","journal-title":"Movement Disorders Clin Practice"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-017-0051-5","volume":"4","author":"Claassen","year":"2017","journal-title":"J Clin Mov Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1017\/S1092852920002655","volume":"26","author":"Frank","year":"2021","journal-title":"CNS Spectr"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology. 2006;66(3):366\u2013372. doi:10.1212\/01.wnl.0000198586.85250.13","DOI":"10.1212\/01.wnl.0000198586.85250.13"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jns.2018.02.008","volume":"389","author":"Frei","year":"2018","journal-title":"J Neurol Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.4088\/JCP.16r10832","volume":"78","author":"Carbon","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/WNL.0000000000003960","volume":"88","author":"Fernandez","year":"2017","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2215-0366(17)30236-5","volume":"4","author":"Anderson","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2217\/cer-2019-0059","volume":"8","author":"Aggarwal","year":"2019","journal-title":"J Comp Eff Res"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94811","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T12:15:11Z","timestamp":1701346511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/clinical-utility-of-deutetrabenazine-as-a-treatment-option-for-chorea--peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s279332","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}